Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Australian Clinical Labs Ltd ( (AU:ACL) ) is now available.
Australian Clinical Labs Ltd has announced a dividend distribution of AUD 0.09 per share for its ordinary fully paid securities. The dividend relates to the six-month period ending on June 30, 2025, with the ex-dividend date set for September 1, 2025, and payment scheduled for September 23, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may positively impact its market positioning by reinforcing investor confidence.
The most recent analyst rating on (AU:ACL) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Australian Clinical Labs Ltd stock, see the AU:ACL Stock Forecast page.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Ltd operates in the healthcare industry, primarily focusing on providing pathology services. The company is known for offering a range of diagnostic testing services across various medical fields, catering to both individual patients and healthcare providers.
Average Trading Volume: 913,236
Technical Sentiment Signal: Sell
Current Market Cap: A$492.9M
Find detailed analytics on ACL stock on TipRanks’ Stock Analysis page.